| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.09 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |